Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase III Randomized Trial of Dose Escalated Radiation in Locally Advanced Pancreas Cancer (LAPC) Patients (LAP100)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06958328
Title field or adapter rule
{'original_value': 'A Phase III Randomized Trial of Dose Escalated Radiation in Locally Advanced Pancreas Cancer (LAPC) Patients (LAP100)', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-31T23:27:26.993775+00:00
Published At
2026-08-25T00:00:00+00:00
Record Updated At
2026-08-25
Source Retrieved At
2026-10-31T22:17:58.991924+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma", "Stage II Pancreatic Cancer AJCC v8", "Stage III Pancreatic Cancer AJCC v8", "Stage IV Pancreatic Cancer AJCC v8"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-08-25", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT06958328"
protocolSection.identificationModule.officialTitle
"A Phase III Randomized Trial of Dose Escalated Radiation in Locally Advanced Pancreas Cancer (LAPC) Patients (LAP100)"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Stage II Pancreatic Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage III Pancreatic Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Pancreatic Cancer AJCC v8 (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['Arm I (Options 1, 2, or 3)', 'Arm II (dose-escalated RT)'], 'description': 'Undergo tumor tissue biopsy', 'name': 'Biopsy Procedure', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm I (Options 1, 2, or 3)', 'Arm II (dose-escalated RT)'], 'description': 'Undergo blood sample collection', 'name': 'Biospecimen Collection', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm I (Options 1, 2, or 3)', 'Arm II (dose-escalated RT)'], 'description': 'Given capecitabine', 'name': 'Capecitabine', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm I (Options 1, 2, or 3)', 'Arm II (dose-escalated RT)'], 'description': 'Undergo CT or PET/CT', 'name': 'Computed Tomography', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm II (dose-escalated RT)'], 'description': 'Undergo dose-escalated radiation using intensity-modulated radiation therapy treatment planning', 'name': 'Dose-escalated Radiation Therapy', 'type': 'RADIATION'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm I (Options 1, 2, or 3)', 'Arm II (dose-escalated RT)'], 'description': 'Given fluorouracil', 'name': 'Fluorouracil', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm I (Options 1, 2, or 3)'], 'description': 'Given gemcitabine', 'name': 'Gemcitabine', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm I (Options 1, 2, or 3)'], 'description': 'Given irinotecan hydrochloride', 'name': 'Irinotecan Hydrochloride', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm I (Options 1, 2, or 3)'], 'description': 'Given liposomal irinotecan', 'name': 'Irinotecan Sucrosofate', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm I (Options 1, 2, or 3)'], 'description': 'Given leucovorin calcium', 'name': 'Leucovorin Calcium', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm I (Options 1, 2, or 3)', 'Arm II (dose-escalated RT)'], 'description': 'Undergo MRI', 'name': 'Magnetic Resonance Imaging', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm I (Options 1, 2, or 3)'], 'description': 'Given nab-paclitaxel', 'name': 'Nab-paclitaxel', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm I (Options 1, 2, or 3)'], 'description': 'Undergo observation', 'name': 'Observation Activity', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm I (Options 1, 2, or 3)'], 'description': 'Given oxaliplatin', 'name': 'Oxaliplatin', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm I (Options 1, 2, or 3)', 'Arm II (dose-escalated RT)'], 'description': 'Undergo PET/CT', 'name': 'Positron Emission Tomography', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm I (Options 1, 2, or 3)', 'Arm II (dose-escalated RT)'], 'description': 'Ancillary studies', 'name': 'Questionnaire Administration', 'type': 'OTHER'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm I (Options 1, 2, or 3)'], 'description': 'Undergo standard radiation therapy', 'name': 'Radiation Therapy', 'type': 'RADIATION'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['Arm I (Options 1, 2, or 3)'], 'description': 'Undergo TTF', 'name': 'Tumor Treating Fields Therapy', 'type': 'PROCEDURE'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

  • Capecitabine (protocolSection.armsInterventionsModule.interventions[].name)
  • Fluorouracil (protocolSection.armsInterventionsModule.interventions[].name)
  • Gemcitabine (protocolSection.armsInterventionsModule.interventions[].name)
  • Irinotecan Hydrochloride (protocolSection.armsInterventionsModule.interventions[].name)
  • Irinotecan Sucrosofate (protocolSection.armsInterventionsModule.interventions[].name)
  • Leucovorin Calcium (protocolSection.armsInterventionsModule.interventions[].name)
  • Nab-paclitaxel (protocolSection.armsInterventionsModule.interventions[].name)
  • Oxaliplatin (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.